influenza

Pfizer and BioNTech Report Promising Results for mRNA-Based Combination Vaccine Against Influenza and COVID-19

(IN BRIEF) Pfizer and BioNTech have announced positive topline results from a Phase 1/2 study of their mRNA-based combination vaccine…

7 months ago

AstraZeneca Highlights Long-Acting Antibodies and Vaccines for At-Risk Individuals at IDWeek Conference

(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting…

7 months ago

Roche’s Xofluza: The Breakthrough Influenza Drug Approved for Children in Europe

(PRESS RELEASE) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics…

1 year ago

Xofluza de Roche: el fármaco innovador contra la gripe aprobado para niños en Europa

(COMUNICADO DE PRENSA) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), un pionero mundial en productos farmacéuticos…

1 year ago

Cambridge and Oxford researchers discovered new molecule that plays a key role in the immune response that is triggered by influenza infections

Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key…

6 years ago

Roche’s phase III CAPSTONE-2 study showed superior efficacy of baloxavir marboxil in reducing influenza symptoms in people at high risk of complications from the flu

Baloxavir marboxil – an investigational oral, single-dose antiviral – is the first flu medicine with a novel proposed mechanism of…

6 years ago

University of Warwick: biotechnology firm VirionHealth receives non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA)

Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced…

6 years ago